Cimpress (CMPR) Earnings Analysis
Cimpress (CMPR) next reports earnings on 2026-07-29, consensus EPS 1.22 USD. Last quarter (2026-04-29) it beat with EPS 0.55 USD vs 0.15 USD est (+266.7%). It has beaten estimates in 3/6 recent quarters (50%). Trailing P/E 52.46.
Last updated 2026-07-23 · Source: FMP fundamentals + earnings calendar (company filings); consensus from sell-side analyst grades
When does CMPR next report earnings?
| Next earnings date | 2026-07-29 |
|---|---|
| Consensus EPS estimate | 1.22 USD |
| Revenue estimate | 0.95B |
CMPR earnings history — beats and misses
| Quarter (report date) | EPS actual | EPS est. | Surprise | Result |
|---|---|---|---|---|
| 2026-04-29 | 0.55 USD | 0.15 USD | +266.7% | Beat |
| 2026-01-28 | 1.95 USD | 1.61 USD | +21.1% | Beat |
| 2025-10-29 | 0.3 USD | 0.29 USD | +3.4% | Beat |
| 2025-04-30 | -0.33 USD | 0.55 USD | -160% | Miss |
| 2025-01-29 | 2.36 USD | 2.52 USD | -6.3% | Miss |
| 2024-10-30 | -0.5 USD | 0.3 USD | -266.7% | Miss |
Beat rate: 3/6 (50%) over reported quarters with consensus data.
CMPR valuation and analyst view
| Trailing P/E | 52.46 |
|---|---|
| Trailing EPS | 1.876 USD |
| Price / book | -4.54 |
| Dividend yield | 0.00% |
| Market cap | 2.42B |
| Analyst consensus | Hold (2 buy / 7 hold / 0 sell) |
| Avg price target | 111.5 USD |
Related research pages
Frequently asked questions
When is Cimpress (CMPR)'s next earnings date?
Cimpress is next scheduled to report on 2026-07-29, with a consensus EPS estimate of 1.22 USD and revenue estimate of 0.95B.
Did CMPR beat earnings last quarter?
In its 2026-04-29 report, CMPR posted EPS of 0.55 USD versus a 0.15 USD estimate — a beat of 266.7%.
What is CMPR's earnings track record?
Over the last 6 reported quarters with consensus data, CMPR beat estimates 3 times (50%).
What is CMPR's current P/E ratio and EPS?
CMPR trades at a trailing P/E of 52.46 on trailing EPS of 1.875581301597859 USD.
What do analysts rate CMPR?
Analyst consensus is "Hold" across 9 ratings (0 strong buy, 2 buy, 7 hold, 0 sell, 0 strong sell). Average 12-month price target: 111.5 USD.